ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer

被引：0
|
作者：
Mc Leer, A. [1 ]
Duruisseaux, M. [2 ]
Pinsolle, J. [2 ]
Dubourg, S. [1 ]
Mondet, J. [1 ]
Phillips-Houlbracq, M. [2 ]
Magnat, N. [1 ]
Faure, J. [3 ]
Chatagnon, A. [3 ]
de Fraipont, F. [1 ]
Levra, M. Giaj [2 ]
Toffart, A. C. [2 ]
Ferretti, G. [4 ]
Brambilla, E. [5 ]
Hainaut, P. [1 ]
Moro-Sibilot, D. [2 ]
Lantuejoul, S. [5 ]
机构：
[1] Hop Michallon, CHU Grenoble, Canc Mol Genet Platform, La Tronche, France
[2] Hop Michallon, CHU Grenoble, Thorac Oncol, La Tronche, France
[3] Hop Michallon, CHU Grenoble, Mol Biol Platform, La Tronche, France
[4] Hop Michallon, CHU Grenoble, Radiol & Imaging Dept, La Tronche, France
[5] Hop Michallon, CHU Grenoble, Dept Pathol, La Tronche, France
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1336P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer
    McLeer-Florin, Anne
    Duruisseaux, Michael
    Pinsolle, Julian
    Dubourd, Sylvian
    Mondet, Julie
    Houlbracq, Mathilde Phillips
    Magnat, Nelly
    Faure, Julien
    Chatagnon, Amandine
    de Fraipont, Florence
    Levra, Matteo Giaj
    Toffart, Anne-Claire
    Ferretti, Gilbert
    Hainaut, Pierre
    Brarribilla, Elisabeth
    Moro-Sibilot, Denis
    Lantuejoul, Sylvie
    LUNG CANCER, 2018, 116 : 15 - 24
  • [2] Crizotinib: A targeted therapy in advanced ALK-positive non-small cell lung cancer
    Toffart, A. -C.
    Sakhri, L.
    Moro-Sibilot, D.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2013, 69 (02) : 111 - 116
  • [3] Variants on a Theme: A Biomarker of Crizotinib Response in ALK-Positive Non-Small Cell Lung Cancer?
    Crystal, Adam S.
    Shaw, Alice T.
    CLINICAL CANCER RESEARCH, 2012, 18 (17) : 4479 - 4481
  • [4] Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non-Small-Cell Lung Cancer
    Yoshida, Tatsuya
    Oya, Yuko
    Tanaka, Kosuke
    Shimizu, Junichi
    Horio, Yoshitsugu
    Kuroda, Hiroaki
    Sakao, Yukinori
    Hida, Toyoaki
    Yatabe, Yasushi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (28) : 3383 - +
  • [5] Differential crizotinib response duration among ALK fusion variants in ALK-positive non-small-cell lung cancer
    Ruano-Ravina, Alberto
    Provencio-Pulla, Mariano
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S54 - S56
  • [6] Clinical observation of crizotinib in the treatment of ALK-positive advanced non-small cell lung cancer
    Deng, Huiyan
    Li, Bin
    Li, Lina
    Peng, Jingcui
    Lv, Tongshuai
    Liu, Yueping
    Ding, Cuimin
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (12)
  • [7] Heterogeneous responses and resistant mechanisms to crizotinib in ALK-positive advanced non-small cell lung cancer
    Kang, Jin
    Chen, Hua-Jun
    Zhang, Xu-Chao
    Su, Jian
    Zhou, Qing
    Tu, Hai-Yan
    Wang, Zhen
    Wang, Bin-Chao
    Zhong, Wen-Zhao
    Yang, Xue-Ning
    Chen, Zhi-Hong
    Ding, Yan
    Wu, Xue
    Wang, Mei
    Fu, Jian-Gang
    Yang, Zhenfan
    Zhang, Xian
    Shao, Yang W.
    Wu, Yi-Long
    Yang, Jin-Ji
    THORACIC CANCER, 2018, 9 (09) : 1093 - 1103
  • [8] Crizotinib: A New Treatment Option for ALK-Positive Non-Small Cell Lung Cancer
    O'Bryant, Cindy L.
    Wenger, Sarah D.
    Kim, Miryoung
    Thompson, Lisa A.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (02) : 189 - 197
  • [9] Better Clinical Outcomes and Resistance Mechanisms of Crizotinib in ALK-Positive Non-Small Cell Lung Cancer
    Zhang, Y.
    Liang, Z.
    Li, Y.
    Yang, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1003 - S1003
  • [10] Clinical presentation of hepatotoxicity-associated crizotinib in ALK-positive (ALK plus ) advanced non-small cell lung cancer (NSCLC).
    Schnell, Patrick
    Safferman, Allan Zachary
    Bartlett, Cynthia Huang
    Tang, Yiyun
    Wilner, Keith D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345